Table 3.
Results of univariate and multivariate analyses of disease free survival
| Variable | Univariate analysis | Multivariate analysis | ||||
| HR | 95% CI | p Value | HR | 95% CI | p Value | |
| Age | ||||||
| Continuous | 1.05 | 1.02–1.09 | <0.001 | 1.07 | 1.03–1.1 | <0.001 |
| pT category | ||||||
| pT4 v pT2-3 | 2.31 | 1.24–4.28 | 0.008 | 3.11 | 1.65–5.86 | <0.001 |
| UICC stage | ||||||
| Stage III v stage II | 1.30 | 0.76–2.25 | 0.34 | 1.41 | 0.80–2.48 | 0.23 |
| Treatment | ||||||
| Surgery+chemotherapy v surgery alone | 1.14 | 0.57–2.29 | 0.70 | na | na | 0.40 |
| Sex | ||||||
| Female v male | 0.99 | 0.56–1.75 | 0.96 | na | na | 0.67 |
| CD95 | ||||||
| Positive v negative | 0.42 | 0.18–0.99 | 0.047 | 0.40 | 0.17–0.94 | 0.036 |
na, not available, because variable was not included in the final model; CI, confidence interval; HR, hazard ratio; UICC, International Union against Cancer.